After symptoms begin but before reality departs, aggressive treatment may forestall the disease. But is the intervention worth the risks?
Long the stuff of science fiction, suspended animation also has a medical history—and it could soon save trauma victims.
Once poised to defeat infectious disease, vaccines beat a long retreat. Now they’re back, and gaining new ground.
Operating in the womb sometimes has miraculous results. Yet many still question whether it should be done at all.
Academia’s role in driving innovation, by Peter L. Slavin and David F. Torchiana.
Readers talk about the problem with lab animals and an important warning about heart disease.
Eric Chivian, founder of the Center for Health and the Global Environment, worries that some medical mysteries may remain forever unsolved as a result of global climate change.
Hospitalists care only for hospitalized patients. Do they confer any benefit over internists?
Universal medical insurance isn’t the golden ticket to universally improved health, warn researchers at the Harvard School of Public Health.
The most popular drug in the world—aspirin—would never have won FDA approval. Fortunately, the active ingredient was isolated in 1828.
Pharmacists propose a third category of drugs—“behind the counter”—which they, not doctors, would prescribe.
Researchers have found the first strong genetic cause to be specifically associated with autism.
Scientists have had only a glimmer of an idea how microbes affect our bodies; a $115 million National Institutes of Health project aims to find out.
Photographer Diane Covert sheds light on victims of terrorist attacks with her photography exhibit featuring x-ray photos of the victims.
The first dermatologist told the writer that she was just seeing things. But finally, magically, the second dermatologist saw what the writer saw.